transferrin has been researched along with Local Neoplasm Recurrence in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 12 (57.14) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Bardou-Jacquet, E; Boudjema, K; Camus, C; Fallet, E; Guyader, D; Houssel-Debry, P; Jezequel, C; Landrieux, A; Legros, L; Rayar, M; Ropert-Bouchet, M; Uguen, T | 1 |
| Furukawa, K; Gocho, T; Hamura, R; Haruki, K; Ikegami, T; Kumamoto, T; Onda, S; Shiozaki, H; Shirai, Y; Taniai, T; Yasuda, J | 1 |
| Asthagiri, AR; Baggenstos, M; Lonser, RR | 1 |
| Gray, BN; Walker, C | 2 |
| Scioscia, KA; Snyderman, CH; Wagner, R | 1 |
| Xie, JF | 1 |
| Chiu, HK; Kim, J; Leung, AM; Pyo, HQ; Schumm, MA; Tseng, CH; Yeh, MW | 1 |
| Akkielah, LA; Alguwaihes, A; Alhaddad, MA; Alhaddad, S; Alharbi, M; Alzahrani, S; Jammah, AA; Masood, A | 1 |
| Dehbi, HM; Hackshaw, A; Harmer, C; Mallick, U; Newbold, K; Wadsley, J | 1 |
| Abujrad, H; Gagnon, A; Irobi, C; Lochnan, HA; Sorisky, A | 1 |
| Campbell, J; Fink-Bennett, D; Wu, D | 1 |
| Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D | 1 |
| Calsolari, MR; Rosario, PW; Siman, TL | 1 |
| Mourão, GF; Rosario, PW | 1 |
| Abelleira, E; Cross, G; Pitoia, F | 1 |
| Rosario, PW; Xavier, AC | 1 |
| Agabiti Rosei, E; Agosti, B; Cappelli, C; Castellano, M; Chiovato, L; De Martino, E; Gandossi, E; Pirola, I; Rotondi, M | 1 |
| Bagnasco, M; Banti, E; Bombardieri, E; Dottorini, ME; Fugazzola, L; Maffioli, L; Perotti, G; Rubello, D; Seregni, E; Testori, O | 1 |
| Gerrard, G; Patel, CN; Prestwich, RJ; Scarsbrook, AF; Viner, S | 1 |
| Calsolari, MR; Furtado, Mde S; Lacerda, RX; Mineiro Filho, AF; Rosario, PW | 1 |
2 review(s) available for transferrin and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Crossing borders: surgically mediated drug delivery techniques.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bacterial Toxins; Biological Availability; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Implants; Exotoxins; Glioma; Humans; Infusion Pumps, Implantable; Interleukin-13; Neoplasm Recurrence, Local; Radioimmunotherapy; Radiotherapy, Adjuvant; Recombinant Fusion Proteins; Recombinant Proteins; Transferrin | 2008 |
[Radiometabolic therapy for metastatic thyroid carcinoma: overview of the literature and rational bases for the use of recombinant human TSH].
Topics: Carcinoma; Clinical Trials, Phase II as Topic; Humans; Iodine Radioisotopes; Italy; Neoplasm Recurrence, Local; Neoplasm, Residual; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa | 2012 |
2 trial(s) available for transferrin and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Aged; Chemoradiotherapy, Adjuvant; Female; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Radiotherapy Dosage; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; United Kingdom; Young Adult | 2019 |
Serum fetuin-A levels following recombinant human thyroid-stimulating hormone stimulation.
Topics: Adult; alpha-2-HS-Glycoprotein; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Thyroid Neoplasms; Thyrotropin Alfa; Thyroxine | 2013 |
17 other study(ies) available for transferrin and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Iron metabolism imbalance at the time of listing increases overall and infectious mortality after liver transplantation.
Topics: Carcinoma, Hepatocellular; End Stage Liver Disease; Female; Ferritins; Follow-Up Studies; Humans; Infections; Iron; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Prospective Studies; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Transferrin | 2020 |
Transferrin predicts outcome in patients who underwent liver resection for colorectal liver metastases.
Topics: Colorectal Neoplasms; Hepatectomy; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Transferrin | 2021 |
Acute-phase reactant proteins and carcinoembryonic antigen in cancer of the colon and rectum.
Topics: Acute-Phase Proteins; Blood Proteins; Carcinoembryonic Antigen; Ceruloplasmin; Colonic Neoplasms; Hexoses; Humans; Neoplasm Recurrence, Local; Prognosis; Rectal Neoplasms; Transferrin | 1983 |
Monitoring of patients with carcinoma of the large intestine by use of acute phase proteins and carcinoembryonic antigen.
Topics: Acute Disease; Adenocarcinoma; C-Reactive Protein; Carcinoembryonic Antigen; Ceruloplasmin; Humans; Intestinal Neoplasms; Intestine, Large; Neoplasm Recurrence, Local; Postoperative Period; Transferrin | 1983 |
Altered serum amino acid profiles in head and neck cancer.
Topics: Adult; Aged; Amino Acids; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Reference Values; Serum Albumin; Transferrin; Weight Loss | 1998 |
[Clinical significance of serum ferritin and acute phase reactant proteins levels in patients with cervical cancer].
Topics: Acute-Phase Proteins; Adult; alpha 1-Antitrypsin; Biomarkers, Tumor; Female; Ferritins; Humans; Middle Aged; Neoplasm Recurrence, Local; Orosomucoid; Transferrin; Uterine Cervical Neoplasms | 1991 |
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer in children, adolescents and young adults.
Topics: Adolescent; Child; Female; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Recombinant Proteins; Retrospective Studies; Thyroid Hormones; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyrotropin Alfa; Young Adult | 2021 |
Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients' Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Biomarkers, Tumor; Combined Modality Therapy; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Young Adult | 2020 |
Thyroid remnant ablation following administration of a diagnostic dose of iodine-131 under thyrogen stimulation.
Topics: Carcinoma; Carcinoma, Papillary; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Postoperative Complications; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Treatment Outcome | 2014 |
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Substance Withdrawal Syndrome; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa; Thyroxine; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Triiodothyronine; Tumor Burden | 2014 |
Day 3 thyroglobulin ≤ 1 ng/ml after recombinant human TSH just prior to radioactive iodine is predictive of low risk for persistent/recurrent disease in patients with papillary thyroid carcinoma.
Topics: Ablation Techniques; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Child; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiography; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Ultrasonography; Whole Body Imaging; Young Adult | 2015 |
Is 131I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Young Adult | 2016 |
Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Treatment Outcome; Young Adult | 2017 |
Recombinant human thyroid stimulating hormone in thyroid remnant ablation with 1.1 GBq 131iodine in low-risk patients.
Topics: Adult; Aged; Autoantibodies; Biopsy, Fine-Needle; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Thyroxine; Time Factors; Treatment Outcome; Ultrasonography | 2012 |
Usefulness of repeated recombinant human thyrotropin-stimulated thyroglobulin test in the post-surgical follow-up of very low-risk patients with differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Papillary; Biological Assay; Cell Differentiation; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Risk Factors; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa | 2012 |
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Tomography, X-Ray Computed; Young Adult | 2012 |
Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Thyroxine; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |